Phase II trial combining nab-paclitaxel (NP), gemcitabine (G) and bevacizumab (B) in patients (pts) with metastatic breast cancer (MBC): NCCTG N0735
- Citation:
- J Clin Oncol vol 29 (suppl) abstr 1126
- Meeting Instance:
- ASCO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2195
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- D. W. Northfelt A. C. Dueck T. P. Flynn P. J. Stella P. J. Zander M. K. Melnik E. S. Pavey E. A. Perez
- Networks:
- Study
- NCCTG-N0735
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: